Literature DB >> 15099024

Activation of matrix metalloproteinase-3 and agrin cleavage in cerebral ischemia/reperfusion.

Sònia Solé1, Valérie Petegnief, Roser Gorina, Angel Chamorro, Anna M Planas.   

Abstract

Matrix metalloproteinase-3 (MMP-3) degrades components of the extracellular matrix and may participate in the pathogenesis of stroke. Here we examine the expression, activation, and cellular location of MMP-3 and the cleavage of agrin, an MMP-3 substrate, following transient middle cerebral artery occlusion in the rat. MMP-3 was activated by ischemia/reperfusion, which was revealed by the appearance of a cleaved form and increased degradation of a substrate. MMP-3 was observed in ischemic neurons, oligodendrocytes, microvasculature, and reactive microglia/macrophages. In cell cultures, MMP-3 expression was observed in neurons and, to a lesser extent, in mature oligodendrocytes, but not in oligodendrocyte progenitors, astrocytes, or microglia. Casein zymography revealed MMP-3 in cultured neurons. Agrin was expressed in cultured neurons and cultured astrocytes. In brain tissue, agrin was detected in neurons, and following ischemia it was also detected in reactive astrocytes. Addition of MMP-3 to protein extracts from control brain caused neuronal agrin degradation. Following ischemia/reperfusion, agrin disappeared from the tissue membrane fraction and a cleaved agrin fragment was found in tissue protein extracts. The present results show MMP-3 activation and neuronal transmembrane agrin cleavage after ischemia/reperfusion. In addition, the finding that MMP-3 cleaves brain agrin strongly suggests that ischemia-induced MMP-3 activation causes agrin cleavage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15099024     DOI: 10.1093/jnen/63.4.338

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  26 in total

1.  Validation of in vivo magnetic resonance imaging blood-brain barrier permeability measurements by comparison with gold standard histology.

Authors:  Angelika Hoffmann; Jörg Bredno; Michael F Wendland; Nikita Derugin; Jason Hom; Tibor Schuster; Hua Su; Peter T Ohara; William L Young; Max Wintermark
Journal:  Stroke       Date:  2011-06-02       Impact factor: 7.914

Review 2.  The vascular basement membrane in the healthy and pathological brain.

Authors:  Maj S Thomsen; Lisa J Routhe; Torben Moos
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

Review 3.  Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers.

Authors:  Ralf G Rempe; Anika M S Hartz; Björn Bauer
Journal:  J Cereb Blood Flow Metab       Date:  2016-06-20       Impact factor: 6.200

4.  Intrathecal Administration of Nanoclusters for Protecting Neurons against Oxidative Stress in Cerebral Ischemia/Reperfusion Injury.

Authors:  Shiyong Li; Dawei Jiang; Emily B Ehlerding; Zachary T Rosenkrans; Jonathan W Engle; Ye Wang; Huisheng Liu; Dalong Ni; Weibo Cai
Journal:  ACS Nano       Date:  2019-10-15       Impact factor: 15.881

5.  Matrix Metalloproteinase-8 is a Novel Pathogenetic Factor in Focal Cerebral Ischemia.

Authors:  Jeong Eun Han; Eun-Jung Lee; Eunjung Moon; Jong Hoon Ryu; Ji Woong Choi; Hee-Sun Kim
Journal:  Mol Neurobiol       Date:  2014-11-26       Impact factor: 5.590

Review 6.  Mechanisms in blood-brain barrier opening and metabolism-challenged cerebrovascular ischemia with emphasis on ischemic stroke.

Authors:  Sajad Sarvari; Faezeh Moakedi; Emily Hone; James W Simpkins; Xuefang Ren
Journal:  Metab Brain Dis       Date:  2020-04-15       Impact factor: 3.584

7.  Mmp-9, a potential target for cerebral ischemic treatment.

Authors:  Xue Dong; Yu-Ning Song; Wei-Guo Liu; Xiu-Li Guo
Journal:  Curr Neuropharmacol       Date:  2009-12       Impact factor: 7.363

Review 8.  Glial activation and matrix metalloproteinase release in cerebral malaria.

Authors:  A Szklarczyk; M Stins; E A Milward; H Ryu; C Fitzsimmons; D Sullivan; K Conant
Journal:  J Neurovirol       Date:  2007       Impact factor: 2.643

9.  Agrin expression during synaptogenesis induced by traumatic brain injury.

Authors:  M Cristina Falo; Thomas M Reeves; Linda L Phillips
Journal:  J Neurotrauma       Date:  2008-07       Impact factor: 5.269

Review 10.  Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.

Authors:  E Candelario-Jalil; Y Yang; G A Rosenberg
Journal:  Neuroscience       Date:  2008-06-19       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.